Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Aurinia Pharm Ord (AUPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 438,741
  • Shares Outstanding, K 84,050
  • Annual Sales, $ 170 K
  • Annual Income, $ -23,300 K
  • 36-Month Beta 2.38
  • Price/Sales 1,044.62
  • Price/Cash Flow N/A
  • Price/Book 2.64

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.76 +9.66%
on 02/06/18
6.11 -14.50%
on 01/24/18
-0.15 (-2.79%)
since 01/16/18
3-Month
4.41 +18.37%
on 12/19/17
6.11 -14.50%
on 01/24/18
+0.03 (+0.58%)
since 11/16/17
52-Week
3.23 +61.61%
on 02/23/17
10.54 -50.47%
on 03/13/17
+1.49 (+39.95%)
since 02/16/17

Most Recent Stories

More News
Aurinia Pharmaceuticals Launches New Lupus Nephritis Disease Awareness Program

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH/TSX:AUP) ("Aurinia" or the "Company"), a clinical stage biopharmaceutical company focused on the global immunology market, today announced that it...

AUP.TO : 6.57 (-0.30%)
AUPH : 5.22 (-1.32%)
Research Reports on Oncolytics Biotech, Aurinia Pharma, Immunovaccine, and IntelliPharmaCeutics

LONDON, UK / ACCESSWIRE / February 12, 2018 / Active-Investors free stock reports for this morning include these Toronto Exchanges' equities from the Biotechnology industry: Oncolytics Biotech, Aurinia...

AUP.TO : 6.57 (-0.30%)
IPCI.TO : 0.87 (-8.42%)
IMV.TO : 2.02 (-0.49%)
AUPH : 5.22 (-1.32%)
ONC.TO : 0.61 (-4.69%)
IPCI : 0.70 (-9.09%)
Aurinia Enhances Commercial and Business Development Expertise with the Appointment of Joseph P. Hagan to its Board of Directors

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) ("Aurinia" or the "Company"), a clinical stage biopharmaceutical company focused on the global immunology market, today announced the...

AUP.TO : 6.57 (-0.30%)
AUPH : 5.22 (-1.32%)
RGLS : 1.20 (-1.64%)
Aurinia to Present at Leerink Partners 7th Annual Global Healthcare Conference

Aurinia Pharmaceuticals Inc., (NASDAQ:AUPH)(TSX:AUP) today announced that its Chief Executive Officer, Richard M. Glickman and Celia Economides, Vice President, Corporate and Public Affairs,...

AUP.TO : 6.57 (-0.30%)
AUPH : 5.22 (-1.32%)
Toronto Exchanges Stock Review, Oncolytics Biotech, Aurinia Pharmaceuticals, Immunovaccine, and IntelliPharmaCeutics International

LONDON, UK / ACCESSWIRE / January 16, 2018 / Active-Investors free stock reports for this morning include these Toronto Exchanges' equities from the Biotechnology industry: Oncolytics Biotech, Aurinia...

AUP.TO : 6.57 (-0.30%)
IPCI.TO : 0.87 (-8.42%)
IMV.TO : 2.02 (-0.49%)
AUPH : 5.22 (-1.32%)
ONC.TO : 0.61 (-4.69%)
IPCI : 0.70 (-9.09%)
Today's Research Reports on Trending Tickers: Aurinia Pharmaceuticals Inc. and INSYS Therapeutics, Inc.

NEW YORK, NY / ACCESSWIRE / January 5, 2018 / On Thursday, all three major indexes rose for the third consecutive day, with the Dow Jones crossing the 25,000 plateau for the first time ever. The Dow Jones...

AUPH : 5.22 (-1.32%)
INSY : 7.79 (-3.83%)
Canadian Exchanges Stock Scanner Oncolytics Biotech, Aurinia Pharmaceuticals, Immunovaccine, and IntelliPharmaCeutics International

LONDON, UK / ACCESSWIRE / December 14, 2017 / Active-Investors free stock reports for this morning include these Toronto Exchanges' equities from the Biotechnology industry: Oncolytics Biotech, Aurinia...

AUP.TO : 6.57 (-0.30%)
IPCI.TO : 0.87 (-8.42%)
IMV.TO : 2.02 (-0.49%)
AUPH : 5.22 (-1.32%)
ONC.TO : 0.61 (-4.69%)
IPCI : 0.70 (-9.09%)
Aurinia Pharmaceuticals Added to the NASDAQ Biotech Index

Aurinia Pharmaceuticals Inc., (NASDAQ: AUPH / TSX: AUP) announced today that it has been selected for addition to the NASDAQ Biotechnology Index(R) (Nasdaq:^NBI), which will become effective...

AUP.TO : 6.57 (-0.30%)
AUPH : 5.22 (-1.32%)
IBB : 110.36 (-0.36%)
Today's Research Reports on Trending Tickers: Achillion Pharmaceuticals and Aurinia Pharmaceuticals

NEW YORK, NY / ACCESSWIRE / November 16, 2017 / U.S. markets dropped sharply Wednesday, with the Dow and S&P 500 posting its largest daily loss since September, as sliding oil prices dragged down the...

AUPH : 5.22 (-1.32%)
ACHN : 3.20 (+4.23%)
Aurinia Reports Third Quarter 2017 Financial Results and Provides Operational Highlights

--Trials in FSGS, MCD and Dry Eye to begin in the first half of 2018

AUP.TO : 6.57 (-0.30%)
AUPH : 5.22 (-1.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Aurinia Pharmaceuticals Inc. is a late stage biopharmaceutical company. It focuses on the development of therapeutic immunomodulating drug candidate. The company's lead drug includes Voclosporin for the treatment of lupus nephritis. Aurinia Pharmaceuticals Inc. is headquartered in Victoria, Canada.

See More

Key Turning Points

2nd Resistance Point 5.38
1st Resistance Point 5.30
Last Price 5.22
1st Support Level 5.17
2nd Support Level 5.12

See More

52-Week High 10.54
Fibonacci 61.8% 7.75
Fibonacci 50% 6.89
Fibonacci 38.2% 6.02
Last Price 5.22
52-Week Low 3.23

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.